Vico Therapeutics is a Dutch biotech company developing novel Antisense-Oligonucleotide (ASO) therapies for rare diseases.
Included in the AvH investment portfolio since 2024.
10.30 %
Beneficial interest AvH
Related participations
Growth Capital
Agidens
provides advice, automation and maintenance services for five focus markets: Life Sciences, Tank Terminals, Food & Beverage, Infrastructure and Chemistry.
Growth Capital
Van Moer Logistics
A leading logistics player in the port of Antwerp, totally committed to multimodal transport: inland shipping combined with rail and road transport.
Growth Capital
Venturi Partners
Singapore-based fund manager with a singular focus on the consumer space in India & South-East Asia.